SI-6603

DRUG3 trials

Sponsors

Seikagaku Corporation

Conditions

Lumbar Disc HerniationLumbar Vertebra Hernia

Phase 2

SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation

CompletedNCT00634946

Seikagaku CorporationLumbar Vertebra Hernia

Start: 2008-01-31End: 2010-08-31Updated: 2023-03-23

Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation

CompletedNCT01282606

Seikagaku CorporationLumbar Vertebra Hernia

Start: 2007-12-31Updated: 2023-03-23

Phase 3

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

CompletedNCT03607838

Seikagaku CorporationLumbar Disc Herniation

Start: 2018-11-07End: 2023-03-21Updated: 2025-07-24

Related Papers

Impact of Condoliase on Health-related Quality of Life in Participants With Radicular Leg Pain Associated With Lumbar Disk Herniation

Spine2025-03-111 citations

A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniation.

2024-08-195 citations

A multicenter, randomized, double-blind, dose-finding study of condoliase in patients with lumbar disc herniation

Journal of Neurosurgery Spine2018-02-0978 citations